reviewThe LancetMar 20, 2019Closed access

Tuberculosis

JFJennifer FurinHCHelen CoxMPMadhukar Pai

Harvard Global Health Institute · Harvard University · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

885
total citations
FWCI
54.24
Percentile
100%
References
153
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Tuberculosis
  • Medicine
  • Rifampicin
  • Latent tuberculosis
  • Rifapentine
  • Mycobacterium tuberculosis
  • Isoniazid
  • Intensive care medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.